TECH OUTLOOKNovember - 202019Biodurobioduro.comCelerioncelerion.comHiFiBiO Therapeuticshifibio.comICON plciconplc.comIDEAYA Biosciencesideayabio.comSirona Dxsironadx.comSumitomo Dainippon Pharma Oncology, Inc.sdponcology.comSynbio Technologies synbio-tech.comSyner-G Pharma Consultingsynergpharma.comTarget RWEtargetrwe.comBioDuro provides a broad range of discovery services with expertise and experienceCelerion is a leader in early clinical research, that delivers Applied Translational MedicineHiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat diseaseICON plc offers a full range of consulting, clinical development and commercialisation services from a global network of offices in 40 countriesIDEAYA is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnosticsA technical CRO that is bridging silos between diagnostics manufacturers and translational clinical research, thereby accelerating the pace of immunotherapy and targeted therapy developmentSumitomo Dainippon Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., LtdSynbio Technologies has created their comprehensive Synotype platforms for biological researchers that dedicate to integrate the cutting edge synthetic biology techniques and bio-informatic tools into an advanced biological innovation platformSyner-G Pharma CMC Consulting is a consulting firm specializing in providing full spectrum of customized CMC Regulatory, Project Management and QA/cGMP services for Bio-Pharmaceutical companiesTarget RWE is an innovative health evidence solutions company generating real-world evidence (RWE) and delivering regulatory-grade data to partners to advance clinical, medical, and commercial outcomes as well as to improve patient health guidelines and quality of careCompanyDescriptiona time. To stay competitive in the increasingly sophisticated technologies and an unstable economic environment, biopharma companies are also increasingly outsourcing research activities to contract research organizations (CROs). Several pharma companies are also implementing machine learning-based deep learning technology to transform the small molecule research field and identify new biologics such as therapeutic antibodies against cancer, fibrosis, and other diseases--this approach has reduced the time-to-market of the antibody therapeutics by 3-18 months. At this juncture, many cutting-edge drug development solution providers and consulting companies are entering the domain with advanced and integrated offerings. To help the pharmaceutical sector strengthen its operational capabilities and simultaneously enable growth in the industry, Pharma Tech Outlook has compiled this edition. The list comprises prominent organizations in the industry that address issues pertinent to drug development by implementing current trends. Besides, the magazine also includes insights from thought leaders TECH OUTLOOK CONSULTING/SERVICE COMPANIES - 2020TOP 10DRUG DISCOVERY AND DEVELOPMENTin the sector on the industry trends, best practices, recent innovations, and their advice for the aspiring CXOs.We present to you Pharma Tech Outlook's, "Top 10 Drug Discovery and Development Solution Providers ­ 2020," and "Top 10 Drug Discovery and Development Consulting/Service Companies ­ 2020."
< Page 9 | Page 11 >